Advances in malignant peritoneal mesothelioma
S Cao, S Jin, J Cao, J Shen, J Hu, D Che, B Pan… - International journal of …, 2015 - Springer
Background Malignant mesothelioma is a rare, insidious, and aggressive tumor arising from
the mesothelial surface of pleural and peritoneal cavities, the pericardium, or the tunica …
the mesothelial surface of pleural and peritoneal cavities, the pericardium, or the tunica …
The role of imaging in diagnosis and management of malignant peritoneal mesothelioma: a systematic review
B Carlson, C Harmath, K Turaga, HL Kindler… - Abdominal …, 2022 - Springer
Purpose Imaging of the peritoneum and related pathology is a challenge. Among peritoneal
diseases, malignant peritoneal mesothelioma (MPeM) is an uncommon tumor with poor …
diseases, malignant peritoneal mesothelioma (MPeM) is an uncommon tumor with poor …
Impact of combination chemotherapy in peritoneal mesothelioma hyperthermic intraperitoneal chemotherapy (HIPEC): the RENAPE study
Background The introduction of cytoreductive surgery (CRS) in combination with
hyperthermic intraperitoneal chemotherapy (HIPEC) improved the prognosis of selected …
hyperthermic intraperitoneal chemotherapy (HIPEC) improved the prognosis of selected …
Does breast MRI background parenchymal enhancement indicate metabolic activity? Qualitative and 3D quantitative computer imaging analysis
E Mema, VL Mango, X Guo, J Karcich… - Journal of Magnetic …, 2018 - Wiley Online Library
Purpose To investigate whether the degree of breast magnetic resonance imaging (MRI)
background parenchymal enhancement (BPE) is associated with the amount of breast …
background parenchymal enhancement (BPE) is associated with the amount of breast …
Two-stage cytoreductive surgery and intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma: predictors of overall survival in an intention-to-treat …
JC Leinwand, RN Taub, JA Chabot… - Annals of Surgical …, 2020 - Springer
Purpose Cytoreductive surgery with intraoperative hyperthermic intraperitoneal
chemotherapy is standard of care for diffuse malignant peritoneal mesothelioma (DMPM) …
chemotherapy is standard of care for diffuse malignant peritoneal mesothelioma (DMPM) …
[HTML][HTML] Quantitative 3D breast magnetic resonance imaging fibroglandular tissue analysis and correlation with qualitative assessments: a feasibility study
Background The amount of fibroglandular tissue (FGT) has been linked to breast cancer risk
based on mammographic density studies. Currently, the qualitative assessment of FGT on …
based on mammographic density studies. Currently, the qualitative assessment of FGT on …
Preventing recurrence of diffuse malignant peritoneal mesothelioma
JC Leinwand, JA Chabot, MD Kluger - Expert Review of Anticancer …, 2016 - Taylor & Francis
Introduction: Diffuse malignant peritoneal mesothelioma (DMPM) is an aggressive
malignancy with a poor prognosis when treated with systemic therapy. Cytoreductive …
malignancy with a poor prognosis when treated with systemic therapy. Cytoreductive …